NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

S&P 500 dips, Nasdaq sinks as investors adjust bets on recovery hopes

Published 11/11/2020, 08:26 am
Updated 11/11/2020, 08:30 am
© Reuters.
EUR/USD
-
GBP/USD
-
XAU/USD
-
US500
-
DJI
-
JP225
-
PFE
-
DX
-
GC
-
LCO
-
CL
-
IXIC
-
US10YT=X
-
US30YT=X
-
STOXX
-
MIAPJ0000PUS
-
MIWD00000PUS
-
DXY
-

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh (Updates to U.S. market close)

By Stephen Culp

NEW YORK, Nov 10 (Reuters) - The S&P 500 posted a modest loss and the Nasdaq closed sharply lower on Tuesday as promising news regarding an effective COVID-19 vaccine led investors away from market leaders and toward cyclical stocks associated with economic recovery.

The blue-chip Dow, buoyed by industrial shares, gained ground and crude oil prices extended the previous session's surge as investors bet on a demand rebound.

Pfizer Inc (NYSE:PFE) PFE.N announced on Monday that its COVID-19 vaccine candidate, developed with German partner BioNTech 22UAy.DE , showed in trials it had a 90% success rate in preventing infection. development led to investors taking profits from market-leading tech stocks that have thrived amid the pandemic recession, a sell-off which pulled the tech-heavy Nasdaq deep into red territory.

"Equity markets in the U.S. have experienced the start of a significant rotation following the vaccine announcement," said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York. "It's been a dramatic change and it's all in anticipation of returning to some form of economic normalcy once the vaccine has been distributed to the broad population."

"The caveat is there's a second wave to the virus that's infecting a record number of people," Ghriskey added. "But at least for now the markets are willing to look through that economic pain to better days ahead once the virus has been eradicated."

Uncertainties from Washington still simmer in the background as President Donald Trump continued to press for investigations of election fraud following his defeat by Democrat challenger Joe Biden. circus going on in DC which is causing concern about a smooth transition of administrations in the months ahead," Ghriskey said. "The flames coming out of Washington are unrelenting and constant."

The Dow Jones Industrial Average .DJI rose 262.95 points, or 0.9%, to 29,420.92, the S&P 500 .SPX lost 4.97 points, or 0.14%, to 3,545.53 and the Nasdaq Composite .IXIC dropped 159.93 points, or 1.37%, to 11,553.86.

European shares extended their gains on lingering vaccine optimism and news that EU negotiators have agreed on a budget, a crucial step toward activating the bloc's 1.8 trillion euro recovery package. pan-European STOXX 600 index .STOXX rose 0.90% and MSCI's gauge of stocks across the globe .MIWD00000PUS %.

Emerging market stocks lost 1.16%. MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS closed 0.69% lower, while Japan's Nikkei .N225 rose 0.26%.

U.S. Treasury yields inched lower on Tuesday in choppy trading, consolidating the previous session's gains due to economic optimism in the wake of positive news on a potential coronavirus vaccine.

Benchmark 10-year notes US10YT=RR last rose 1/32 in price to yield 0.9561%, from 0.958% late on Monday.

The 30-year bond US30YT=RR last rose 7/32 in price to yield 1.7408%, from 1.751% late on Monday.

Oil prices extended Monday's surge, which gave the commodity its biggest daily percentage gain in five months, as views of a possible medical solution to the pandemic outweighed sagging demand from new lockdowns to contain the virus. crude CLcv1 rose 2.66% to settle at $41.36 per barrel, while Brent settled at $43.61 per barrel, up 2.85% on the day.

The dollar held its ground against a basket of currencies and the yen hovered near three-week lows as the forex markets absorbed Monday's big moves due to vaccine developments. dollar index .DXY rose 0.08%, with the euro EUR= down 0.05% to $1.1807.

The Japanese yen strengthened 0.08% versus the greenback at 105.30 per dollar, while Sterling GBP= was last trading at $1.3249, up 0.65% on the day.

Gold regained some ground lost in Monday's plunge expectations of fiscal and monetary stimulus offered support to the safe-haven metal. gold XAU= added 0.6% to $1,873.53 an ounce.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j Stocks hit new highs

https://tmsnrt.rs/38vx2mG

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.